High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis

International Journal of Neuroscience

Volumn 117, Issue 11, 2007, Pages 1505-1512

  Yapici, Z ^a   Tuzun E ^b,e   Altunayoglu V ^c   Erdogan A ^d   Eraksoy, M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^d Taksim Education and Training Hospital   (Turkey)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Autoimmunity; Complement; Cytokine; Interleukin 10; Juvenile myasthenia gravis; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; MALE; MYASTHENIA GRAVIS; ONSET AGE; PATHOGENESIS; PEDIATRICS; PROTEIN BLOOD LEVEL; TREATMENT RESPONSE;

ANTIBODIES; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; COMPLEMENT C3; COMPLEMENT C4; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2; MALE; MYASTHENIA GRAVIS; RECEPTORS, CHOLINERGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35148895179     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450601125840     Document Type: Article

References (14)

1. Ashraf, V. V., Taly, A. B., Veerendrakumar, M., & Rao, S. (2006). Myasthenia gravis in children: a longitudinal study. Acta Neurologica Scandinavica, 114(2), 119-123.
2. Balasa, B., Deng, C., Lee, J., Bradley, L. M., Dalton, D. K., Christadoss, P., & Sarvetnick, N. (1997). Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. Journal of Experimental Medicine, 186(3), 385-391.
3. Deng, C., Goluszko, E., Tuzun, E., Yang, H., & Christadoss, P. (2002). Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production. Journal of Immunology, 169(2), 1077-1083.
4. Girndt, M. (2002). Humoral immune responses in uremia and the role of IL-10. Blood Purif, 20(5), 485-488.
5. Goluszko, E., Deng, C., Poussin, M. A., & Christadoss, P. (2002). Tumor necrosis factor receptor p55 and p75 deficiency protectsmice from developing experimental autoimmune myasthenia gravis. Journal of Neuroimmunology, 122(1-2), 85-93.
6. Hohlfeld, R., Conti-Tronconi, B., Kalies, I., Bertrams, J., & Toyka, K. V. (1985). Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis. Journal of Immunology, 135(4), 2393-2399.
7. Poussin, M. A., Goluszko, E., David, C. S., Franco, J. U., & Christadoss, P. (2001). HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production. Journal of Autoimmun, 17(3), 175-180.
8. Poussin, M. A., Goluszko, E., Franco, J. U., & Christadoss, P. (2002). Role of IL-5 during primary and secondary immune response to acetylcholine receptor. Journal of Neuroimmunology, 125(1-2), 51-58.
9. Poussin, M. A., Goluszko, E., Hughes, T. K., Duchicella, S. I., & Christadoss, P. (2000). Suppression of experimental autoimmune myasthenia gravis in IL-10 genedisrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR. Journal of Neuroimmunology, 111(1-2), 152-160.
10. Spellberg, B., & Edwards, J. E., Jr. (2001). Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis, 32(1), 76-102.
11. Tuzun, E., Meriggioli, M. N., Rowin, J., Yang, H., & Christadoss, P. (2005). Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment. Journal of Autoimmun, 24(3), 261-268.
12. Tuzun, E., Scott, B. G., Goluszko, E., Higgs, S., & Christadoss, P. (2003). Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis. Journal of Immunology, 171(7), 3847-3854.
13. Utsugisawa, K., Nagane, Y., Obara, D., Kondoh, R., Yonezawa, H., & Tohgi, H. (2003). Interleukin-2 production by peripheral blood mononuclear cells from patients with myasthenia gravis. European Neurology, 49(3), 160-163.
14. Zhang, G. X., Navikas, V., & Link, H. (1997). Cytokines and the pathogenesis of myasthenia gravis. Muscle Nerve, 20(5), 543-551.